Specific inhibitor of FGF receptor signaling: FGF‐2‐mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte‐lineage cells
Authors:
- 21 October 2003
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 74 (4) , 486-493
Abstract
Multiple studies have shown that migration, proliferation, and differentiation of oligodendrocyte (OL) lineage cells are influenced by fibroblast growth factor‐2 (FGF‐2) signaling through its receptors (FGFR) FGFR‐1, FGFR‐2, and FGFR‐3. We report the effectiveness and specificity of a unique inhibitor, PD173074, for inhibiting FGF receptor signaling in OL‐lineage cells. Three FGF‐mediated responses of OL progenitors and two of differentiated OLs were examined by immunofluorescence microscopy and immunoblotting. PD173074 effectively antagonized the effect of FGF‐2 on proliferation and differentiation of OL progenitors in culture. One dose of PD173074 at nanomolar concentrations was sufficient to inhibit ongoing FGF‐2 mediated proliferation for prolonged periods, in a non‐toxic, dose‐dependent manner. In contrast, platelet‐derived growth factor (PDGF)‐induced proliferation was unaffected by PD173074. Similarly, mitogen‐activated protein kinase (MAPK) activation, a downstream event after activation of either FGFR or PDGFR, was also blocked by PD173074 in OL progenitors stimulated with FGF‐2 but not PDGF. A general tyrosine kinase inhibitor (PD166285), however, antagonized both FGF‐2‐ and PDGF‐mediated responses. PD173074 also completely antagonized two phenotypic alterations of differentiated OLs, specifically downregulation of myelin proteins, and their re‐entry into the cell cycle. We conclude that PD173704 is an effective and specific inhibitor for multiple FGF‐2‐mediated responses of both OL progenitors and differentiated OLs. This inhibitor provides a direct approach for identifying the importance of FGF signaling, comparable in effect to a knockout of all FGF receptors and all FGF ligands, while leaving other pathways unaffected. Thus, PD173704 is an excellent tool for investigating the role of FGF signaling in vivo in the context of combinatorial interactions of other signals.Keywords
This publication has 51 references indexed in Scilit:
- An ‘oligarchy’ rules neural developmentTrends in Neurosciences, 2002
- Fibroblast Growth Factor-2 (FGF-2) and Platelet-Derived Growth Factor AB (PDGFAB) Promote Adult SVZ-Derived Oligodendrogenesis in VivoMolecular and Cellular Neuroscience, 2002
- Syndecan‐3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrixJournal of Neuroscience Research, 2002
- Oligodendrocyte Precursor Migration and Differentiation: Combined Effects of PSA Residues, Growth Factors, and SubstratesMolecular and Cellular Neuroscience, 2000
- PDGF and FGF-2 Signaling in Oligodendrocyte Progenitor Cells: Regulation of Proliferation and Differentiation by Multiple Intracellular Signaling PathwaysMolecular and Cellular Neuroscience, 2000
- Fate Determination and Migration of Progenitors in the Postnatal Mammalian CNSDevelopmental Neuroscience, 1997
- Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migrationGlia, 1997
- Regulation of Oligodendrocyte Development and CNS Myelination by Growth Factors: Prospects for Therapy of Demyelinating DiseaseBrain Pathology, 1996
- Developmental and FGF-2-Mediated Regulation of Syndecans (1–4) and Glypican in OligodendrocytesMolecular and Cellular Neuroscience, 1996
- The inhibition of oligodendrocytic differentiation of O‐2A progenitors caused by basic fibroblast growth factor is overridden by astrocytesGlia, 1993